Stock Performance: Rocket Lab's stock experienced a 27% drop following a delay in the Neutron rocket launch, but has since partially recovered, trading around $47.
Financial Growth: The company reported record revenue of $155 million in Q3, secured 17 Electron contracts, and has a backlog of $1.05 billion, indicating strong demand and growth potential.
Analyst Ratings: Despite the launch delay, analysts rate Rocket Lab as a moderate buy with a high target price of $83, suggesting a potential upside of 77% over the next year.
Market Potential: Rocket Lab operates in a sector with a projected total addressable market of $10 billion by 2030, positioning it for significant growth if it can capture a substantial share.
